Susceptibility to primary sclerosing cholangitis is associated with a polymorphism of the MMP-9 (gelatinase B) gene

Susceptibility to primary sclerosing cholangitis is associated with a polymorphism of the MMP-9 (gelatinase B) gene

Opis bibliograficzny
Główni autorzy:	Cullen, SN, Jewell, D, Chapman, R
Format:	Journal article
Wydane:	2002

Podobne zapisy

Association between genetic polymorphism in matrix metalloproteinase 2 (MMP-2, gelatinase A) and susceptibility to primary sclerosing cholangitis
od: Cullen, SN, i wsp.
Wydane: (2003)

No association between Nod2 polymorphisms and susceptibility to, or progression of, primary sclerosing cholangitis
od: Cullen, SN, i wsp.
Wydane: (2002)

Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.
od: Yang, X, i wsp.
Wydane: (2004)

A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.
od: Satsangi, J, i wsp.
Wydane: (2001)

The medical management of primary sclerosing cholangitis.
od: Cullen, SN, i wsp.
Wydane: (2006)

A regulatory polymorphism of the stromelysin gene (MMP-3) strongly influences susceptibility to primary sclerosing cholangitis (PSC) and progression to portal hypertension.
od: Satsangi, J, i wsp.
Wydane: (2000)

Primary sclerosing cholangitis.
od: Cullen, S, i wsp.
Wydane: (2003)

Tumour necrosis factor alpha (TNF) gene haplotypes and primary sclerosing cholangitis
od: Cullen, SN, i wsp.
Wydane: (2003)

Review article: current management of primary sclerosing cholangitis.
od: Cullen, SN, i wsp.
Wydane: (2005)

Etiopathogenesis of primary sclerosing cholangitis.
od: Chapman, R, i wsp.
Wydane: (2008)

Aetiopathogenesis of primary sclerosing cholangitis.
od: Cullen, S, i wsp.
Wydane: (2001)

Immunopathogenesis of primary sclerosing cholangitis.
od: Worthington, J, i wsp.
Wydane: (2005)

Primary sclerosing cholangitis--an immunologically mediated disease?
od: Chapman, R, i wsp.
Wydane: (1985)

Primary sclerosing cholangitis
od: Chapman, R
Wydane: (2007)

Primary sclerosing cholangitis.
od: Chapman, R
Wydane: (1985)

Primary sclerosing cholangitis.
od: Mitchell, SA, i wsp.
Wydane: (2000)

Primary sclerosing cholangitis.
od: Williamson, K, i wsp.
Wydane: (2014)

Primary sclerosing cholangitis.
od: Worthington, J, i wsp.
Wydane: (2006)

Primary sclerosing cholangitis
od: Chapman Roger, i wsp.
Wydane: (2006-10-01)

The management of primary sclerosing cholangitis.
od: Chapman, R
Wydane: (2003)

The immunology of primary sclerosing cholangitis.
od: Chapman, R
Wydane: (1990)

Primary sclerosing cholangitis - Foreword
od: Chapman, R
Wydane: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
od: Chapman, R
Wydane: (1993)

Deposition of complement C 9 in primary sclerosing cholangitis.
od: Shanahan, J, i wsp.
Wydane: (1998)

Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism.
od: Norris, S, i wsp.
Wydane: (2001)

An update on primary sclerosing cholangitis.
od: Maggs, JR, i wsp.
Wydane: (2008)

The management of primary sclerosing cholangitis.
od: Mitchell, SA, i wsp.
Wydane: (1998)

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
od: Cullen, SN, i wsp.
Wydane: (2006)

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis
od: Chapman, R, i wsp.
Wydane: (1986)

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
od: Chapman, R, i wsp.
Wydane: (1986)

PORTAL TRACT LYMPHOCYTE POPULATIONS IN PRIMARY SCLEROSING CHOLANGITIS
od: Snook, J, i wsp.
Wydane: (1987)

Deposition of complement C9 in primary sclerosing cholangitis (PSC).
od: Shanahan, J, i wsp.
Wydane: (1998)

Small duct primary sclerosing cholangitis.
od: Chapman, R
Wydane: (2002)

MEDICAL TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS
od: Chapman, R
Wydane: (1994)

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
od: Cullen, SN, i wsp.
Wydane: (2008)

Chemoprevention and screening in primary sclerosing cholangitis.
od: Kitiyakara, T, i wsp.
Wydane: (2008)

Liver transplantation for primary sclerosing cholangitis.
od: Gow, P, i wsp.
Wydane: (2000)

Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
od: Chiranjeevi Padala, i wsp.
Wydane: (2017-01-01)

Sclerosing cholangitis
od: Martins, E, i wsp.
Wydane: (1998)

Sclerosing cholangitis
od: Martins, E, i wsp.
Wydane: (1997)